These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32360550)

  • 21. Medical and dental applications of nanomedicines.
    Kavoosi F; Modaresi F; Sanaei M; Rezaei Z
    APMIS; 2018 Oct; 126(10):795-803. PubMed ID: 30264432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current State of Nanomedicines in the Treatment of Topical Infectious Disorders.
    Thakur K; Sharma G; Singh B; Chhibber S; Katare OP
    Recent Pat Antiinfect Drug Discov; 2018; 13(2):127-150. PubMed ID: 29807522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanotechnology for the diagnosis and treatment of diseases.
    Azzawi M; Seifalian A; Ahmed W
    Nanomedicine (Lond); 2016 Aug; 11(16):2025-7. PubMed ID: 27509317
    [No Abstract]   [Full Text] [Related]  

  • 24. Nanovesicles for Nanomedicine: Theory and Practices.
    Wadhwa S; Garg V; Gulati M; Kapoor B; Singh SK; Mittal N
    Methods Mol Biol; 2019; 2000():1-17. PubMed ID: 31148004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conference Scene: nanomedicine kindles the development of the 'elixir of life'.
    Jain S; Das M
    Nanomedicine (Lond); 2011 Jun; 6(4):599-603. PubMed ID: 21718173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnology-based intelligent drug design for cancer metastasis treatment.
    Gao Y; Xie J; Chen H; Gu S; Zhao R; Shao J; Jia L
    Biotechnol Adv; 2014; 32(4):761-77. PubMed ID: 24211475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Critical Review of the Use of Surfactant-Coated Nanoparticles in Nanomedicine and Food Nanotechnology.
    Miyazawa T; Itaya M; Burdeos GC; Nakagawa K; Miyazawa T
    Int J Nanomedicine; 2021; 16():3937-3999. PubMed ID: 34140768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scientists' perception of ethical issues in nanomedicine: a case study.
    Silva Costa H; Sethe S; Pêgo AP; Olsson IA
    Nanomedicine (Lond); 2011 Jun; 6(4):681-91. PubMed ID: 21506689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanodelivery systems for improved topical antimicrobial therapy.
    Basnet P; Škalko-Basnet N
    Curr Pharm Des; 2013; 19(41):7237-43. PubMed ID: 23489202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology enables superior medical therapies.
    Foldvari M; Elsabahy M
    Curr Drug Deliv; 2011 May; 8(3):225-6. PubMed ID: 21291383
    [No Abstract]   [Full Text] [Related]  

  • 31. Thinking small, doing big: Current success and future trends in drug delivery systems for improving cancer therapy with special focus on liver cancer.
    Limeres MJ; Moretton MA; Bernabeu E; Chiappetta DA; Cuestas ML
    Mater Sci Eng C Mater Biol Appl; 2019 Feb; 95():328-341. PubMed ID: 30573256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploiting endocytosis for nanomedicines.
    Akinc A; Battaglia G
    Cold Spring Harb Perspect Biol; 2013 Nov; 5(11):a016980. PubMed ID: 24186069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of nanoscience and nanotechnology on controlled drug delivery.
    Youan BB
    Nanomedicine (Lond); 2008 Aug; 3(4):401-6. PubMed ID: 18694301
    [No Abstract]   [Full Text] [Related]  

  • 35. (Phospho)lipid-based Nanosystems for Skin Administration.
    Vanić Z; Holæter AM; Skalko-Basnet N
    Curr Pharm Des; 2015; 21(29):4174-92. PubMed ID: 26323431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead.
    Grotz E; Tateosian N; Amiano N; Cagel M; Bernabeu E; Chiappetta DA; Moretton MA
    Pharm Res; 2018 Sep; 35(11):213. PubMed ID: 30238168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tunable resistive pulse sensing: potential applications in nanomedicine.
    Sivakumaran M; Platt M
    Nanomedicine (Lond); 2016 Aug; 11(16):2197-214. PubMed ID: 27480794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.
    Raza F; Zafar H; You X; Khan A; Wu J; Ge L
    J Mater Chem B; 2019 Dec; 7(48):7639-7655. PubMed ID: 31746934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomedicines for kidney diseases.
    Williams RM; Jaimes EA; Heller DA
    Kidney Int; 2016 Oct; 90(4):740-5. PubMed ID: 27292222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.